Clinical Chemistry Standards
ABclonal Technology Cardiac Troponin I TNNI3
Troponin I (TnI) along with TnT and TnC forms the troponin complex in striated muscle where TnI inhibits actin-myosin interactions mediating muscle relaxation The TnI subfamily includes TnI-skeletal-fast-twitch TnI-skeletal-slow-twitch and TnI-cardiac with this gene encoding the cardiac isoform expressed only in cardiac muscle Mutations in this gene cause familial hypertrophic cardiomyopathy type 7 (CMH7) and familial restrictive cardiomyopathy (RCM) TnI is a key diagnostic marker for heart failure ischemic heart disease and acute myocardial injury including in COVID-19 patients where elevated levels indicate increased mortality risk particularly in those with pre-existing cardiovascular conditions
Abcam Lyophilized E x osome Standard (100 µg, Human Serum), 2VIAL
This product is manufactured by BioVision, an Abcam company and was previously called M1043 ExoStd™ Lyophilized Exosome Standard (100 μg, Human Serum, 2 vials).
The product is subject to the following: Abcam Restricted Use Statement
RJM Sales Inc STANDARDS KIT ETHANOL
Standards Kit, Ethanol (2 g/L, 3.2 g/L)
Abcam Evans blue, L-glutamate uptake inhibitor, 1G
MW 960.8 Da, Purity >95%. Potent inhibitor of L-glutamate uptake via the membrane bound excitatory amino acid transporter (EAAT). Able to antagonize AMPA and kainate receptor mediated currents (IC₅₀ values are 220 and 150 nM, respectively). Binds with high affinity to serum albumin.
The product is subject to the following: Abcam Restricted Use Statement
Cayman Chemical 5-Octyl D-glutamate, Purity: ≥98%, CAS: 149332-65-0, 5 mg
A cell-permeable form of D-glutamate; generates free D-glutamate upon hydrolysis of the ester bond by cytoplasmic esterases; may be used to increase levels of cytoplasmic D-glutamate
Abcam cis-ACBD (1-Aminocyclobutane-1,3-dicarbo x ylic acid), L-glutamate uptake inhibitor, 10MG
MW 159.14 Da. Selective, competitive L-glutamate uptake inhibitor (IC₅₀ = 30 μM). Increases basal and potassium evoked D-aspartate release.
The product is subject to the following: Abcam Restricted Use Statement
Abcam DL-AP4 sodium salt (mM/ml), Glutamate antagonist, 100MM_ML
MW 205.08 Da, Purity >99%. Broad spectrum glutamate receptor antagonist. Achieve your results faster with highly validated, pure and trusted compounds.
The product is subject to the following: Abcam Restricted Use Statement
Abcam DL-AP4, glutamate antagonist, 1G
MW 183.1 Da, Purity >99%. Broad spectrum glutamate antagonist. Water-soluble form available - please see DL-AP4 sodium salt (ab120253).
The product is subject to the following: Abcam Restricted Use Statement
Abcam L-AP4, group III mGlu agonist, 1MG
MW 183.1 Da, Purity >99%. Selective group III mGlu agonist. Achieve your results faster with highly validated, pure and trusted compounds.
The product is subject to the following: Abcam Restricted Use Statement
Abcam DL-AP5, NMDA glutamate site antagonist, 50MG
MW 197.13 Da, Purity >99%. Competitive NMDA receptor glutamate site antagonist. Also available as the sodium salt (ab120271).
The product is subject to the following: Abcam Restricted Use Statement
Abcam DL-AP4, glutamate antagonist, 100MG
MW 183.1 Da, Purity >99%. Broad spectrum glutamate antagonist. Water-soluble form available - please see DL-AP4 sodium salt (ab120253).
The product is subject to the following: Abcam Restricted Use Statement
Roche Diagnostics COBAS C(501) INTERNAL STANDARD
reag, for Roche analyzer, Cobas C501, internal standard gen 2
